Sector consensus BioRestorative Therapies, Inc.
Stocks
BRTX
US0906556065
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
16:00:00 2026-08-13 EDT
|
5-day change | 1st Jan Change | ||
| 0.2202 USD | +3.72% |
|
+5.66% | -81.26% |
| 07-16 | BioRestorative Therapies, Inc. Announces CEO Changes, Effective July 13, 2026 | CI |
| 07-16 | BioRestorative Therapies, Inc. Announces CFO Changes, Effective July 13, 2026 | CI |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | - | 8 | +3,533.06% | 2 | |||||
| 182.53 | +12.45% | 18 | ||||||
| - | - | - | - | - | ||||
| 200.05 | +58.35% | 22 | ||||||
| 40.89 | +4.01% | 23 | ||||||
| 104.26 | +30.84% | 20 | ||||||
| 2,410.59 | +19.04% | 15 | ||||||
| 1,216.34 | -15.82% | 7 | ||||||
| 570.05 | +8.48% | 18 | ||||||
| 52.94 | +4.6% | 16 | ||||||
| 678.06 | +33.64% | 16 | ||||||
| 110.18 | +28.73% | 11 | ||||||
| 21.11 | +103.62% | 13 | ||||||
| 144.21 | +61.97% | 21 | ||||||
| 109.9 | +49.63% | 20 | ||||||
| 124.71 | +22.45% | 14 | ||||||
| 99.56 | +40.43% | 16 | ||||||
| 85.5 | +1.26% | 10 | ||||||
| 109 | +85.19% | 9 | ||||||
| 12.75 | +66.67% | 4 | ||||||
| Average | 330.56 | +218.35% | 14 | ||||||
| Weighted average by Cap. | 369.11 | +27.48% | 17 |
- Stock Market
- Stocks
- BRTX Stock
- Sector BioRestorative Therapies, Inc.
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
